Approval · Notice of Compliance 17299 · 2015
INDAPAMIDE: Notice of Compliance 17299
Issued September 21, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17299
- Date
- September 21, 2015
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companioes
- Canadian reference product
- LOZIDE (Servier Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INDAPAMIDE | 02445824 | Cancelled Post Market |
| INDAPAMIDE | 02445832 | Cancelled Post Market |
Medicinal ingredients
- INDAPAMIDE 1.25 MG per TAB
- INDAPAMIDE 2.5 MG per TAB